BM-derived CD34+ HSPCs from individuals with MDS showed significantly higher ALPK1 mRNA levels compared with the age-matched controls (Fig. 3g), correlating with a worse prognosis (Fig. 3h). The gene discussed is ALPK1; the disease is myelodysplastic syndrome.